Patently Wrong! Monsanto species patent on soy beans upheld in Munich
Submitted by ETC Staff on
After delays, denial, and double standards, Monsanto maintains unjust monopoly on major food crop. Time to talk to the cooks about a new recipe?
Monsanto's Species-Wide Patent on Trial
Submitted by ETC Staff on
Remember 1994? Nine years ago: Yasser Arafat, Yitzhak Rabin, and Shimon Peres won the Nobel Peace Prize, Nelson Mandela was elected President of South Africa, US President Bill Clinton sent ground troops to the Persian Gulf to counter a move by Iraq's Saddam Hussein, and Brazil won the World Cup. The United Nations' Biodiversity Convention entered into force in 1994 and the Uruguay Round of GATT was drawing to a close. In the "life sciences" cosmos, Monsanto and Dupont were chemical companies with minor interests in seeds and Syngenta did not yet exist. ETC Group was known as RAFI. Also in 1994, a small biotech subsidiary of W.R. Grace, Agracetus, won a breathtakingly broad patent on all genetically modified soybean varieties, European Patent No. 301,749.
Broken Promise? Monsanto Promotes Terminator Seed Technology
Submitted by ETC Staff on
At its annual meeting on Thursday, April 24th 2003, Monsanto's top brass will greet shareholders with a dismal financial report, (a 15% drop in annual sales - $4.7 billion in 2002, down from $5.5 billion in 2001) and a shareholder resolution that urges the company to re-think the safety of genetically engineered seeds - now the company's flagship product. But there's potentially more troubling news - a little known position paper that could rattle shareholders, irk investors and erode public confidence still further in the biotech behemoth: Despite its 1999 pledge not to commercialize Terminator technology, Monsanto has recently adopted a positive stance on genetic seed sterilization, a technology that has been condemned by civil society and some governments as an immoral application of genetic engineering.
Size Matters!
Submitted by ETC Staff on
The ETC Group today (14.04.2003) releases a new Occasional Paper, "No Small Matter II: The Case for a Global Moratorium - Size Matters!" The report calls on governments to adopt a moratorium on synthetic nanomaterials that are being manufactured in the laboratory and in some cases commercialized, in the absence of testing for health, safety and environmental impacts.
"Even though industry is scaling up the manufacture of nanoparticles and carbon nanotubes there appear to be no government regulations in Europe or North America to ensure the safety of workers or consumers," says Kathy Jo Wetter, ETC Group researcher. "A few national governments are beginning to consider some aspects of nanotech regulation but no government is giving full consideration to the socioeconomic, environmental, and health implications of this powerful new industry," notes Wetter. The ETC Group reports that nanoparticles are already available to consumers in sunscreens (including some intended for children, from infancy onwards) and cosmetics, among other products. However, regulators do not test nano-sized materials for health, safety and environmental impacts if their macro- or micro-sized counterparts have already been approved.
El tamaño sí importa
Submitted by ETC Staff on
Nueva evidencia de los riesgos de las nano partículas El Grupo ETC publicó el 14 de abril 2003 un nuevo documento de la serie Occasional Papers, con el título "Size Matters! No small matter II: The Case for a Global Moratorioum." El informe llama a los gobiernos a adoptar una moratoria sobre los nano materiales sintéticos que se están fabricando en los laboratorios y en algunos casos ya se están comercializando, ante la ausencia de pruebas sobre su inocuidad para la salud, la seguridad y sus impactos ambientales.